Answers are grounded in this paper and cite their sources.
The association between psoriasis disease duration and complete skin clearance after biologic initiation remains uncertain. This single-centre retrospective study included 218 biologic-naïve patients who initiated biologic therapy between 2010 and 2024. Disease duration was defined as the interval from symptom onset to biologic initiation and categorized as ≤2 years or >2 years. Absolute Psoriasis Area and Severity Index (PASI) 0 was assessed at 3 months, 6 months, 1 year and 2 years using an as-observed approach. Twenty-nine patients (13.3%) had disease duration ≤2 years. At 3 months, absolute PASI 0 was achieved in 6/29 (20.7%) patients with shorter disease duration and 14/189 (7.4%) with longer disease duration (p=0.033). No significant differences were detected at subsequent assessments. In an exploratory multivariable Cox model including baseline PASI, shorter disease duration was associated with early PASI 0 achievement (hazard ratio 4.75; 95% confidence interval 1.57-14.40). Sparse early events and incomplete covariate data limit interpretation. Shorter disease duration was associated with earlier complete skin clearance; larger studies are needed to establish whether this association is independent of treatment selection and other confounders.
No takes yet. Share an insight, caveat, or question.
Hiura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: